Franklin Biotechnology Discovery Fund

Portfolio Statistics

Assets

Total Fund AssetsAs of 05/31/2020 (updated monthly) $1,306.2 (M)
Net Assets - Class C As of 05/31/2020 (updated monthly) $54.2 (M)

Positions As of 06/30/2020

Equity VS. NASDAQ Biotechnology Index

Fund Benchmark
Market CapitalizationAs of 06/30/2020 (updated monthly) $31,635.16(M) $41,108.81(M)
P/B RatioAs of 06/30/2020 (updated monthly) 6.33 5.75
P/E Ratio (12-mo Forward)As of 06/30/2020 (updated monthly) 18.29 17.43
Price to Cash FlowAs of 06/30/2020 (updated monthly) 19.70 16.54

Portfolio Details

Asset AllocationAs of 06/30/2020

[name] [value]
Equity 95.65%
Cash & Cash Equivalents 4.35%

Geographic BreakdownAs of 06/30/2020

No chart available for this data.
[name] [value]
United States 82.65%
Cash & Cash Equivalents 4.35%
United Kingdom 4.07%
Netherlands 3.13%
Denmark 2.30%
Canada 2.08%
Switzerland 0.90%
Germany 0.54%

sector breakdownAs of 06/30/2020

[name] [value]
Biotechnology 77.37%
Pharmaceuticals 13.28%
Life Sciences Tools & Services 4.78%
Cash & Cash Equivalents 4.35%
Health Care Equipment 0.22%

TOP TEN HOLDINGSAs of 06/30/2020

Issuer Country Industry % of total
VERTEX PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 7.16%
REGENERON PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 6.71%
AMGEN INC United States Pharmaceuticals, Biotechnology & Life Sciences 5.51%
ILLUMINA INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.78%
GILEAD SCIENCES INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.53%
NOVAVAX INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.34%
GW PHARMACEUTICALS PLC United Kingdom Pharmaceuticals, Biotechnology & Life Sciences 3.79%
BIOGEN INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.71%
REATA PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 2.87%
IOVANCE BIOTHERAPEUTICS INC United States Pharmaceuticals, Biotechnology & Life Sciences 2.86%

Market Capitalization BreakdownAs of 06/30/2020

[name] [value]
<2.0 Billion 17.13%
2.0-5.0 Billion 26.48%
5.0-10.0 Billion 12.95%
10.0-25.0 Billion 8.53%
25.0-50.0 Billion 3.88%
>50.0 Billion 30.01%
N/A 1.02%